Survival with three-times weekly in-center nocturnal versus conventional hemodialysis

Journal of the American Society of Nephrology

Volumn 23, Issue 4, 2012, Pages 687-695

  Lacson, Eduardo ^a   Xu, Jianglin ^a   Suri, Rita S ^b   Nesrallah, Gihad ^b   Lindsay, Robert ^b   Garg, Amit X ^b   Lester, Keith ^a   Ofsthun, Norma ^a   Lazarus, Michael ^a   Hakim, Raymond M ^a  

^a FRESENIUS MEDICAL CARE NORTH AMERICA   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM; HEMOGLOBIN; PHOSPHORUS;

ADULT; AGE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CONVENTIONAL HEMODIALYSIS; FEMALE; HEMODIALYSIS; HUMAN; IN CENTER NOCTURNAL HEMODIALYSIS; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION; WEIGHT GAIN;

EID: 84859861074     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011070674     Document Type: Article

References (30)

1. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, AllonM, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R Hemodialysis (HEMO) StudyGroup: Effect of dialysis dose andmembrane flux in maintenance hemodialysis. N Engl JMed 347: 2010-2019, 2002 (Pubitemid 35461657)
2. Suri RS, Garg AX, Chertow GM, Levin NW, Rocco MV, Greene T, Beck GJ, Gassman JJ, Eggers PW, Star RA, Ornt DB, Kliger AS Frequent Hemodialysis Network Trial Group: Frequent Hemodialysis Network (FHN) randomized trials: Study design. Kidney Int 71: 349-359, 2007 (Pubitemid 46227095)
3. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS FHN Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363: 2287-2300, 2010
4. Ramkumar N, Beddhu S, Eggers P, Pappas LM, Cheung AK: Patient preferences for in-center intense hemodialysis. Hemodial Int 9: 281-295, 2005 (Pubitemid 41131077)
5. Centers for Medicare & Medicaid Services (CMS), HHS: Medicare program; End-stage renal disease prospective payment system. Final rule. Fed Regist 75: 49029-49214, 2010
6. Cahill M, Payne G: Online mentoring: ANNAConnections. Nephrol Nurs J 33: 695-697, 2006
7. Lacson E Jr, Lazarus M: Dialysis time: Does it matter? A reappraisal of existing literature. Curr Opin Nephrol Hypertens 20: 189-194, 2011
8. Troidle L, Hotchkiss M, Finkelstein F:A thriceweekly in-center nocturnal hemodialysis program. Adv Chronic Kidney Dis 14: 244-248, 2007 (Pubitemid 46977283)
9. Bugeja A, Dacouris N, Thomas A, Marticorena R, McFarlane P, Donnelly S, Goldstein M: In-center nocturnal hemodialysis: Another option in the management of chronic kidney disease. Clin J AmSoc Nephrol 4: 778-783, 2009
10. Cravedi P, Ruggenenti P, Mingardi G, Sghirlanzoni MC, Remuzzi G: Thrice-weekly in-center nocturnal hemodialysis: An effective strategy to optimize chronic dialysis therapy. Int J Artif Organs 32: 12-19, 2009
11. David S, Kümpers P, Eisenbach GM, Haller H, Kielstein JT: Prospective evaluation of an in-centre conversion from conventional haemodialysis to an intensified nocturnal strategy. Nephrol Dial Transplant 24: 2232-2240, 2009
12. Koch BC, Hagen EC, Nagtegaal JE, Boringa JB, Kerkhof GA, Ter Wee PM: Effects of nocturnal hemodialysis on melatonin rhythm and sleep-wake behavior: An uncontrolled trial. AmJ Kidney Dis 53: 658-664, 2009
13. Powell JR, Oluwaseun O, Woo YM, Padmanabhan N, Narasinghan E, Latta C, Tortolano J, Jardine AG, Geddes CC: Ten years experience of in-center thrice weekly long overnight hemodialysis. Clin J Am Soc Nephrol 4: 1097-1101, 2009
14. Troidle L, Finkelstein F, Hotchkiss M, Leypoldt JK: Enhanced solute removal with intermittent, in-center, 8-hour nocturnal hemodialysis. Hemodial Int 13: 487-491, 2009
15. Lacson E Jr, Wang W, Lester K, Ofsthun N, Lazarus JM, Hakim RM: Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Clin J Am Soc Nephrol 5: 220-226, 2010
16. Ok E, Duman S, Asci G, Tumuklu M, Onen SO, Kayikcioglu M, Toz H, Adam SM, Yilmaz M, Tonbul HZ, Ozkahya M: Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: A prospective, case-controlled study. Nephrol Dial Transplant 26: 1287-1296, 2011
17. Johansen KL, Zhang R, Huang Y, Chen SC, Blagg CR, Goldfarb- Rumyantzev AS, Hoy CD, Lockridge RS Jr, Miller BW, Eggers PW, Kutner NG: Survival and hospitalizationamong patients using nocturnal and short daily compared to conventional hemodialysis: A USRDS study. Kidney Int 76: 984-990, 2009
18. Pauly RP, Maximova K, Coppens J, Asad RA, Pierratos A, Komenda P, Copland M, Nesrallah GE, Levin A, Chery A, Chan CT CAN-SLEEP CollaborativeGroup: Patient and technique survival among a Canadian multicenter nocturnal home hemodialysis cohort. Clin J Am Soc Nephrol 5: 1815-1820, 2010
19. DeSoi CA, Umans JG: Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol 4: 1214-1218, 1993
20. Eloot S, Van Biesen W, Dhondt A, Van de Wynkele H, Glorieux G, Verdonck P, Vanholder R: Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 73: 765-770, 2008 (Pubitemid 351323256)
21. Lacson E Jr, Wang W, Hakim RM, Teng M, Lazarus JM: Associates of mortality and hospitalization in hemodialysis: Potentially actionable laboratory variables and vascular access. Am J Kidney Dis 53: 79-90, 2009
22. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006 (Pubitemid 44215354)
23. Lacson E Jr, Ikizler TA, Lazarus JM, Teng M, Hakim RM: Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs. J Ren Nutr 17: 363-371, 2007 (Pubitemid 47633465)
24. Miller JE, Kovesdy CP, Norris KC, Mehrotra R, Nissenson AR, Kopple JD, Kalantar-Zadeh K: Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol 32: 403-413, 2010
25. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69: 1222-1228, 2006
26. Movilli E, Gaggia P, Zubani R, Camerini C, Vizzardi V, Parrinello G, Savoldi S, Fischer MS, Londrino F, Cancarini G: Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transplant 22: 3547-3552, 2007 (Pubitemid 350212498)
27. Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79: 250-257, 2011
28. Flythe JE, Brunelli SM: The risks of high ultrafiltration rate in chronic hemodialysis: implications for patient care. SeminDial 24: 259-265, 2011
29. United States Renal Data System: USRDS Annual Data Report: Atlas of Chronic Kidney and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
30. Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, VanWyck D, Greenland S, Kalantar-Zadeh K: Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis 55: 100-112, 2010